Le Lézard
Classified in: Science and technology
Subjects: CALENDAR OF EVENTS, ANNUAL MEETINGS

Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar


HAMILTON, Ontario, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, wishes to inform shareholders that it will be hosting a webinar on March 2, 2022 at 6:00am PST / 9:00am EST to review the Company's quarterly financial statements for Q2 Fiscal Year 2022 (October 1 ? December 31, 2021), and provide a corporate update.

Webinar Login Information:

  Date: Wednesday, March 2, 2022
  Time: 6:00am PST / 9:00am EST
  URL: www.reliqhealth.com/webinar
   

For those who are not able to attend the webinar, a recording will be available on the Company's website (www.reliqhealth.com) immediately following the session.

Reliq Health

Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director

For further information please contact:

Company Contact
Investor Relations at [email protected]

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.



These press releases may also interest you

at 07:05
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...

at 07:05
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available...

at 07:05
FiscalNote Holdings, Inc. ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of global policy and market intelligence, today announced that members of the senior management team will be participating in the following upcoming...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC)...

at 07:05
TransAlta Corporation ("TransAlta" or the "Company") today reported its financial results for the first quarter ended March 31, 2024, demonstrating strong operational and financial performance and reaffirming its 2024 outlook. First Quarter 2024...

at 07:05
AtmosFX, the holiday decorating company known for inventing projection-based home decorating, is revealing all seven of the new digital decoration collections it will be releasing in 2024 with a very special...



News published on and distributed by: